Conference Coverage

VIDEO: U.S. hypertension guidelines reset threshold to 130/80 mm Hg


 

EXPERT ANALYSIS FROM THE AHA SCIENTIFIC SESSIONS

– Thirty million Americans became hypertensive overnight on Nov. 13 with the introduction of new high blood pressure guidelines from the American College of Cardiology and American Heart Association.

That happened by resetting the definition of adult hypertension from the long-standing threshold of 140/90 mm Hg to a blood pressure at or above 130/80 mm Hg, a change that jumps the U.S. adult prevalence of hypertension from roughly 32% to 46%. Nearly half of all U.S. adults now have hypertension, bringing the total national hypertensive population to a staggering 103 million.

Another 12% have what’s now called elevated blood pressure, with a systolic pressure of 120-129 mm Hg but a normal diastolic of less than 80 mm Hg – a group that warrants lifestyle interventions to arrest progression. That leaves a mere 42% of American adults now classified as normotensive. In selected subgroups, the prevalence numbers grow even more inflated. Among African American men and women, 55% now have hypertension. And among men and women aged 65 years or older, more than three-quarters now have hypertension.

Goal is to transform care

But the new guidelines (J Am Coll Cardiol. 2017 Nov 13. doi: 10.1016/j.jacc.2017.11.005) for preventing, detecting, evaluating, and managing adult hypertension do lots more than just shake up the epidemiology of high blood pressure. With 106 total recommendations, the guidelines seek to transform every aspect of blood pressure in American medical practice, starting with how it’s measured and stretching to redefine applications of medical systems to try to ensure that every person with a blood pressure that truly falls outside the redefined limits gets a comprehensive package of interventions.

Dr. Paul K. Whelton Mitchel L. Zoler/Frontline Medical News

Dr. Paul K. Whelton

The new guidelines include not just new approaches to blood pressure measurement and definition, but also a new risk-based approach to making a treatment decision, a reduced treatment target of less than 130/80 mm Hg, and new strategies to improve treatment efficacy, said Paul K. Whelton, MD, chair of the guidelines task force and professor of global health at Tulane University in New Orleans, in presenting the guidelines during the American Heart Association scientific sessions.

Many of these are “seismic changes,” said Lawrence J. Appel, MD. He particularly cited as seismic the new classification of stage 1 hypertension as a pressure at or above 130/80 mm Hg, the emphasis on using some form of out-of-office blood pressure measurement to confirm a diagnosis, the use of risk assessment when deciding whether to treat certain patients with drugs, and the same blood pressure goal of less than 130/80 mm Hg for all hypertensives, regardless of age, as long as they remain ambulatory and community dwelling.

One goal for all adults

“The systolic blood pressure goal for older people has gone from 140 mm Hg to 150 mm Hg and now to 130 mm Hg in the space of 2-3 years,” commented Dr. Appel, professor of epidemiology at Johns Hopkins University in Baltimore and not involved in the guideline-writing process.

In fact, the guidelines simplified the treatment goal all around, to less than 130/80 mm Hg for patients with diabetes, those with chronic kidney disease, and the elderly; that goal remains the same for all adults.

“It will be clearer and easier now that everyone should be less than 130/80 mm Hg. You won’t need to remember a second target,” said Sandra J. Taler, MD, a nephrologist and professor of medicine at the Mayo Clinic in Rochester, Minn., and a member of the guidelines task force.

“Some people may be upset that we changed the rules on them. They had normal blood pressure yesterday, and today it’s high. But it’s a good awakening, especially for using lifestyle interventions,” Dr. Taler said in an interview.

Preferred intervention: Lifestyle, not drugs

Lifestyle optimization is repeatedly cited as the cornerstone of intervention for everyone, including those with elevated blood pressure with a systolic pressure of 120-129 mm Hg, and as the only endorsed intervention for patients with hypertension of 130-139 mm Hg but below a 10% risk for a cardiovascular disease event during the next 10 years on the American College of Cardiology’s online risk calculator. The guidelines list six lifestyle goals: weight loss, following a DASH diet, reducing sodium, enhancing potassium, 90-150 min/wk of physical activity, and moderate alcohol intake.

Dr. Robert M. Carey Mitchel L. Zoler/Frontline Medical News

Dr. Robert M. Carey

The guidelines may be a “can opener for a recommitment to lifestyle changes” for preventing and managing hypertension, said the task force’s vice chair, Robert M. Carey, MD, professor of medicine at the University of Virginia in Charlottesville.

Pages

Recommended Reading

Cognitive decline not seen with lower BP treatment targets
MDedge Endocrinology
Metabolically healthy obese still at elevated cardiovascular risk
MDedge Endocrinology
Older men benefit from vascular screening
MDedge Endocrinology
Higher BP targets suggested for elderly, cognitively impaired
MDedge Endocrinology
How to lower blood pressure in real-world primary care clinics
MDedge Endocrinology
New ADA hypertension and diabetes treatment guide features visual aid
MDedge Endocrinology
How to apply SPRINT findings to elderly patients
MDedge Endocrinology
BP accuracy is the ghost in the machine
MDedge Endocrinology
HOPE-3 wades into fray regarding optimal blood pressure targets
MDedge Endocrinology
Low-sodium DASH benefits increase with higher blood pressures
MDedge Endocrinology